Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...

Partnerships Events News

Webinar: Clinical Exomes to Reporting

By Carl Smith on May 30, 2023

1

Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.

Conferences Events News

Saphetor at ESHG 2023

By Carl Smith on May 15, 2023

0

Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.

News

Inside Precision Medicine IVDR Interview

By Carl Smith on January 4, 2023

0

Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...

Press Releases Partnerships News

G42 Healthcare strengthens clinical genomics offering with Saphetor’s VarSome bioinformatics platform, strengthens UAE’s position as a global leader in healthcare innovation

By Carl Smith on October 24, 2022

0

VarSome is exhibiting at this year's ASHG annual meeting in Los Angeles.

Conferences Partnerships Events News

VarSome at ASHG 2022

By Carl Smith on October 20, 2022

0

RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...

Press Releases Partnerships News

King Faisal Specialist Hospital & Research Centre to Power Genomic Interpretation with VarSome

By Carl Smith on September 28, 2022

0

Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...

Press Releases Partnerships News

Instand-NGS4P tender selects Saphetor's VarSome

By Carl Smith on September 15, 2022

0

Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...

Press Releases News

Saphetor Partners with PTC Therapeutics to advance awareness of clinical programs in rare diseases

By Carl Smith on July 12, 2022

0

Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.

Press Releases News

Saphetor in Nature Portfolio's Biopharma Dealmakers

By Carl Smith on April 13, 2022

0

Partnerships VarSome Clinical News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms

By Carl Smith on March 29, 2022

0

VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.

Events News

VarSome at ASHG 2021

By Carl Smith on October 19, 2021

0

Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...

News

Saphetor in Forbes

By Carl Smith on September 3, 2021

1